MASSACHUSETTS FINANCIAL SERVICES CO /MA/
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 912938
Boston, MA
Position in VRTX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$210,141,127
+$63,900,174 QoQ
Shares Held
423,049
+29.2% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#70
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 12%
None 6%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $2,249,676,327 across 65 Biotechnology names. VRTX ranks #3 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
1,875,301 | $500,180,281 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
2,012,317 | $376,866,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
423,049 | $210,141,127 | |
| 4 | TECH |
BIO-TECHNE Corp
|
2,746,462 | $194,037,538 | |
| 5 | SRRK |
Scholar Rock Holding Corp
|
2,607,348 | $143,404,140 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
375,762 | $118,774,610 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
350,560 | $105,529,075 | |
| 8 | BNTX |
BioNTech SE
|
677,708 | $63,060,728 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $210,141,127 | 423,049 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $146,240,953 | 327,498 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $96,082,395 | 211,934 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $197,057,579 | 503,160 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $571,794,399 | 1,284,354 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $981,715,893 | 2,024,908 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $921,578,141 | 2,288,498 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,351,385,279 | 2,905,705 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,287,110,741 | 2,746,012 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,172,178,621 | 2,804,188 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,475,302,572 | 3,625,802 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,353,332,441 | 3,891,794 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,386,919,887 | 3,941,121 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,274,467,915 | 4,045,031 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,187,334,848 | 4,111,555 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,258,552,490 | 4,346,731 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,223,563,737 | 4,342,112 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $917,349,474 | 3,515,153 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $701,551,286 | 3,194,678 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $571,240,641 | 3,149,240 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $635,898,068 | 3,153,787 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $613,858,210 | 2,856,616 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $622,545,318 | 2,634,109 | Shares | Sole | 2021-05-12 | |
| 2020-09-30 | $517,070,721 | 1,900,157 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $524,962,055 | 1,808,281 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $291,913,727 | 1,226,786 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||